PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.85%
Negative revenue growth while MTDR stands at 12.82%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.81%
Negative gross profit growth while MTDR is at 5.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
-99.24%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-99.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-111.83%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-111.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-111.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.95%
Slight or no buybacks while MTDR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-1.40%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.94%
Dividend reduction while MTDR stands at 27.13%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-0.20%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-45.62%
Negative 10Y revenue/share CAGR while MTDR stands at 274.24%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
37.22%
5Y revenue/share CAGR under 50% of MTDR's 194.43%. Michael Burry would suspect a significant competitive gap or product weakness.
-35.73%
Negative 3Y CAGR while MTDR stands at 62.76%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
118.92%
10Y OCF/share CAGR under 50% of MTDR's 379.95%. Michael Burry would worry about a persistent underperformance in cash creation.
37.14%
Below 50% of MTDR's 172.74%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
35.18%
3Y OCF/share CAGR at 50-75% of MTDR's 63.27%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-116.97%
Negative 10Y net income/share CAGR while MTDR is at 173.53%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-881.48%
Negative 5Y net income/share CAGR while MTDR is 742.79%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.25%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-40.25%
Negative equity/share CAGR over 10 years while MTDR stands at 248.72%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
2.11%
Below 50% of MTDR's 161.88%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
99.68%
3Y equity/share CAGR at 50-75% of MTDR's 153.48%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-12.61%
Cut dividends over 10 years while MTDR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
206.22%
Dividend/share CAGR of 206.22% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
112.49%
Below 50% of MTDR's 408.78%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-17.21%
Firm’s AR is declining while MTDR shows 8.02%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-72.85%
Negative asset growth while MTDR invests at 2.14%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.96%
We have a declining book value while MTDR shows 8.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.13%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
16.67%
SG&A declining or stable vs. MTDR's 42.78%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.